Revelation Biosciences
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Revelation Biosciences generated cash of -$7,286,286, which is more than the previous year. Cash used in financing activities reached the amount of $14,025,008 last year. Net change in cash is therefore $6,738,722.

Cash Flow

Revelation Biosciences, Inc. (NASDAQ:REVBU): Cash Flow
2019 0 0 0
2020 -215.07K -74.03M 74.26M
2021 -11.09M -131.96K 8.00M
2022 -11.21M 0 15.19M
2023 -7.28M 0 14.02M

REVBU Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
5.25M1.27M4.49M74.24M0
Operating activities
Net income
-120.25K-10.82M-11.98M-1.63M-3.63K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
25.04K25.04K16.78K00
Stock-based compensation expense
155.72K301.11K470.87K43.84K0
Deferred income tax benefit 155.72K301.11K470.87K43.84K0
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
749.66K-666.04K-269.64K30.13K0
Cash generated by operating activities
-7.28M-11.21M-11.09M-215.07K0
Investing activities
Purchases Of Investments
000-74.03M0
Investments In Property Plant And Equipment
-40-131.96K00
Acquisitions Net
00000
Cash generated by investing activities
00-131.96K-74.03M0
Financing activities
Common Stock Issued
14.03M4.46M8.00M74.24M-10K
Payments for dividends
00000
Repurchases of common stock
-5K-7.65M000
Repayments of term debt
0-796.88K0-15K0
Cash used in financing activities
14.02M15.19M8.00M74.26M0
Net Change In Cash
6.73M3.97M-3.21M-74.23M0
Cash at end of period
11.99M5.25M1.27M11.73K0
Data sourceData sourceData sourceData source